Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2026)
Sight Sciences (SGHT) recorded quarterly Cash from Financing Activities of $88000.0 in Q1 2026, down 93.04% quarter-over-quarter from $1.3 million in Q4 2025, and up 450.0% on a YoY basis from $16000.0 in Q1 2025.
Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Sight Sciences' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $88000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 450.0% year-over-year to $88000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 68.54% YoY), while the FY2025 annual figure was $1.8 million, down 63.92% from the prior year.
- Cash from Financing Activities was $88000.0 for Q1 2026 at Sight Sciences, down from $1.3 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $5.4 million in Q4 2024 to a low of -$942000.0 in Q1 2024.
- Historically, Cash from Financing Activities has averaged $540882.4 across 5 years, with a median of $158000.0 in 2022.
- Biggest YoY gain for Cash from Financing Activities was 1333.24% in 2024; the steepest drop was 503.85% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $812000.0 in 2022, then plunged by 53.69% to $376000.0 in 2023, then soared by 1333.24% to $5.4 million in 2024, then slumped by 76.53% to $1.3 million in 2025, then sank by 93.04% to $88000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $88000.0 (Q1 2026), $1.3 million (Q4 2025), and $25000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sight Sciences | 284.28 Mn | 199.32 Mn | 16.98 Mn | 88,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 5.39 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Mar 31, 2024 | -942,000.00 |
| Mar 31, 2024 | -942,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Dec 31, 2023 | 376,000.00 |